InMode Defends Its Feminine Rejuvenation Patent Against BTL Industries' Review Request
InMode Defends Its Feminine Rejuvenation Patent Against BTL Industries' Review Request
InMode Ltd. (NASDAQ:INMD), a leading global provider of innovative medical technologies, responded to the recent petition to the U.S. Patent & Trademark Office filed by BTL Industries, Inc., in which BTL asks the USPTO to conduct an Inter Partes Review of InMode's U.S. Patent No. 8,961,511. Six months before BTL's petition, InMode sued BTL in the United States District Court for the Central District of California alleging that BTL's UltraFemme 360 and EmFemme 360 non-invasive, radio-frequency based feminine rejuvenation products infringe the patent. That litigation is ongoing.
全球領先的創新醫療技術提供商InMode有限公司（納斯達克股票代碼：INMD）回應了BTL工業公司最近向美國專利商標局提交的請願書，其中BTL要求美國專利商標局對InMode的美國專利號8,961,511進行各方間審查。在BTL提出請願前六個月，InMode在美國加利福尼亞中區地方法院起訴了BTL，指控BTL的UltraFemme 360和EmFemme 360非侵入性、基於射頻的女性嫩膚產品侵犯了該專利。該訴訟仍在進行中。